BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 32145873)

  • 1. Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin.
    Takabayashi T; Schleimer RP
    J Allergy Clin Immunol; 2020 Mar; 145(3):740-750. PubMed ID: 32145873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
    Takeno S; Taruya T; Ueda T; Noda N; Hirakawa K
    Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Airway Inflammation in Eosinophilic Chronic Rhinosinusitis as Determined by Exhaled Nitric Oxide.
    Kambara R; Minami T; Akazawa H; Tsuji F; Sasaki T; Inohara H; Horii A
    Int Arch Allergy Immunol; 2017; 173(4):225-232. PubMed ID: 28848094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.
    Ho J; Bailey M; Zaunders J; Mrad N; Sacks R; Sewell W; Harvey RJ
    Clin Exp Allergy; 2015 Feb; 45(2):394-403. PubMed ID: 25429730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.
    Tojima I; Kouzaki H; Shimizu S; Ogawa T; Arikata M; Kita H; Shimizu T
    Clin Immunol; 2016 Sep; 170():1-8. PubMed ID: 27422491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in number of mast cells in resected nasal polyps as an indicator for postoperative recurrence of chronic rhinosinusitis.
    Teranishi Y; Jin D; Takano S; Sunami K; Takai S
    Immun Inflamm Dis; 2019 Sep; 7(3):191-200. PubMed ID: 31210032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
    Tojima I; Shimizu T
    Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):18-25. PubMed ID: 30507713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of peripheral lymph node addressin in human nasal mucosa with eosinophilic chronic rhinosinusitis.
    Tsutsumiuchi T; Hoshino H; Fujieda S; Kobayashi M
    Pathology; 2019 Apr; 51(3):268-273. PubMed ID: 30837082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γδT cells contribute to type 2 inflammatory profiles in eosinophilic chronic rhinosinusitis with nasal polyps.
    Li X; Wang Z; Chang L; Chen X; Yang L; Lai X; Li S; Huang J; Huang Z; Wu X; Bellanti JA; Zheng SG; Zhang G
    Clin Sci (Lond); 2019 Nov; 133(22):2301-2315. PubMed ID: 31722010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological mechanisms and clinical features of eosinophilic chronic rhinosinusitis in the Japanese population.
    Takeno S; Hirakawa K; Ishino T
    Allergol Int; 2010 Sep; 59(3):247-256. PubMed ID: 20567131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Poposki JA; Uzzaman A; Nagarkar DR; Chustz RT; Peters AT; Suh LA; Carter R; Norton J; Harris KE; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Schleimer RP; Kato A
    J Allergy Clin Immunol; 2011 Jul; 128(1):73-81.e4. PubMed ID: 21497884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus.
    Takabayashi T; Imoto Y; Sakashita M; Kato Y; Tokunaga T; Yoshida K; Narita N; Ishizuka T; Fujieda S
    Allergol Int; 2017 Oct; 66(4):594-602. PubMed ID: 28389065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis.
    Jang YJ; Lim JY; Kim S; Lee Y; Kweon MN; Kim JH
    Front Immunol; 2018; 9():2330. PubMed ID: 30455684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking neutrophils and eosinophils in chronic rhinosinusitis.
    Delemarre T; Bochner BS; Simon HU; Bachert C
    J Allergy Clin Immunol; 2021 Aug; 148(2):327-335. PubMed ID: 33895002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophils and mast cells: a comparison of nasal mucosa histology and cytology to markers in nasal discharge in patients with chronic sino-nasal diseases.
    Gröger M; Bernt A; Wolf M; Mack B; Pfrogner E; Becker S; Kramer MF
    Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2667-76. PubMed ID: 23430080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 inflammation suppression by T-regulatory cells attenuates the eosinophil recruitment in mucosa of chronic sinusitis.
    Chang L; Wang Z; Li S; Chen X; Li X; Zhao J; Lai X; Huang J; Wu X; Huang Z; Bellanti JA; Zheng SG; Zhang G
    Clin Sci (Lond); 2020 Jan; 134(2):123-138. PubMed ID: 31922185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps.
    Takabayashi T; Kato A; Peters AT; Suh LA; Carter R; Norton J; Grammer LC; Tan BK; Chandra RK; Conley DB; Kern RC; Fujieda S; Schleimer RP
    J Allergy Clin Immunol; 2012 Aug; 130(2):410-20.e5. PubMed ID: 22534535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
    Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
    J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps.
    Nakayama T; Sugimoto N; Okada N; Tsurumoto T; Mitsuyoshi R; Takaishi S; Asaka D; Kojima H; Yoshikawa M; Tanaka Y; Haruna SI
    Auris Nasus Larynx; 2019 Jun; 46(3):374-383. PubMed ID: 30243753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis.
    Yoshida K; Takabayashi T; Imoto Y; Sakashita M; Narita N; Fujieda S
    Allergol Int; 2019 Apr; 68(2):225-232. PubMed ID: 30348485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.